CrossAmerica Partners Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q2, CrossAmerica Partners (NYSE:CAPL) earned $13.97 million, a 176.72% increase from the preceding quarter. CrossAmerica Partners also posted a total of $1.48 billion in sales, a 34.95% increase since Q1.

According to Benzinga Pro, during Q2, CrossAmerica Partners (NYSE:CAPL) earned $13.97 million, a 176.72% increase from the preceding quarter. CrossAmerica Partners also posted a total of $1.48 billion in sales, a 34.95% increase since Q1. CrossAmerica Partners earned $5.05 million, and sales totaled $1.09 billion in Q1.

What Is ROCE?

Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, CrossAmerica Partners posted an ROCE of 0.2%.

It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company’s recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows CrossAmerica Partners is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For CrossAmerica Partners, the positive return on capital employed ratio of 0.2% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Analyst Predictions

CrossAmerica Partners reported Q2 earnings per share at $0.35/share, which beat analyst predictions of $0.33/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit

Hemp-focused consumer wellness company CV Sciences, Inc. (OTCQB: CVSI) announced on Thursday its financial results for the year ended Dec. 31, 2023. The San Diego-based company reported a gross margin of 44.3% for fiscal year 2023, representing an improvement from 34.2% for 2022. For the fourth quarter gross margin was 45.8%, representing a sequential improvement from 45.1% in the third quarter. "Our 2023 progress demonstrates our continuous commitment to innovation and cost-efficient execution as we move closer to profitability and positive cash flow," Joseph Dowling, CEO of CV Sciences, said. "As the CBD category consolidates, we have increased our market share in key sales channels, including the natural product retail channel. We will continue to focus our resources on new product development, as evidenced by our pet line expansion with our recent launch of pet chews for hip and joint health and calming care."

CVSI